Ogkologos

4396 ΔΗΜΟΣΙΕΥΣΕΙΣ 0 ΣΧΟΛΙΑ

Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and...

Ogkologos - 14 Απριλίου, 2026

OS Advantage of Gotistobart Over Docetaxel in Patients with anti-PD‑(L)1- and...

Ogkologos - 14 Απριλίου, 2026

Safety and Antitumour Activity of Setidegrasib in Patients with Previously Treated...

Ogkologos - 13 Απριλίου, 2026

EMA Recommends Granting a Marketing Authorisation for Poherdy

Ogkologos - 10 Απριλίου, 2026

Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with...

Ogkologos - 9 Απριλίου, 2026

FDA Approves Relacorilant with nab-Paclitaxel for Platinum-Resistant Epithelial Ovarian, Fallopian Tube,...

Ogkologos - 8 Απριλίου, 2026

Efficacy of Pembrolizumab and Olaparib Combination Observed in a Subset of Patients with HRD Metastatic Pancreatic Cancer

Ogkologos - 7 Απριλίου, 2026

Nomination Process for the 2026 ESMO Society Awards Now Open

Ogkologos - 7 Απριλίου, 2026

EMA Recommends Extension of Therapeutic Indications for Asciminib

Ogkologos - 3 Απριλίου, 2026

NHS England Lung Cancer Screening Programme Demonstrates that it is Feasible and Scalable...

Ogkologos - 3 Απριλίου, 2026

1...202122...440 Σελίδα 21 από 440

MOST POPULAR

FDA Grants Accelerated Approval to Umbralisib for Marginal Zone and Follicular...

11 Φεβρουαρίου, 2021

Green Beret With Lung Cancer Surprised With Hundreds Of ‘Thank You’...

17 Δεκεμβρίου, 2020

EMA Adopts Positive Opinion for Pemetrexed Baxter

3 Νοεμβρίου, 2022

England: Smoking responsible for twice as many cancers in most deprived...

2 Αυγούστου, 2021

Φόρτωση περισσοτέρων

Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and...

OS Advantage of Gotistobart Over Docetaxel in Patients with anti-PD‑(L)1- and...

Safety and Antitumour Activity of Setidegrasib in Patients with Previously Treated...

EMA Recommends Granting a Marketing Authorisation for Poherdy

Whole-Genome Sequencing Meets Diagnostic Requirements in Routine Practice for Patients with...

FDA Approves Relacorilant with nab-Paclitaxel for Platinum-Resistant Epithelial Ovarian, Fallopian Tube,...

Efficacy of Pembrolizumab and Olaparib Combination Observed in a Subset of Patients with HRD Metastatic Pancreatic Cancer

Nomination Process for the 2026 ESMO Society Awards Now Open

EMA Recommends Extension of Therapeutic Indications for Asciminib

NHS England Lung Cancer Screening Programme Demonstrates that it is Feasible and Scalable...

MOST POPULAR

FDA Grants Accelerated Approval to Umbralisib for Marginal Zone and Follicular...

Green Beret With Lung Cancer Surprised With Hundreds Of ‘Thank You’...

EMA Adopts Positive Opinion for Pemetrexed Baxter

England: Smoking responsible for twice as many cancers in most deprived...

HOT NEWS

Male Patients with Cancer at Higher Risk of Severe Disease Course...

Reducing Health Care Disparities Through Cancer Clinical Trials

What to Know About At-Home DNA Tests for Detecting Cancer Risk

EMA Recommends Granting a Conditional Marketing Authorisation for Amivantamab

ΔΗΜΟΦΙΛΕΊΣ ΘΈΣΕΙΣ

ΚΑΡΚΙΝΟΣ ΘΥΜΟΥ ΑΔΕΝΑ (ΘΥΜΩΜΑ)

ΣΤΑΤΙΣΤΙΚΑ

ΚΕΝΤΡΙΚΟΥ ΝΕΥΡΙΚΟΥ ΣΥΣΤΗΜΑΤΟΣ

ΔΗΜΟΦΙΛΗ ΚΑΤΗΓΟΡΙΑ